The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedicx Fund Regulatory News (MXF)

  • There is currently no data for MXF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - MedicX Fund Limited

4 Feb 2019 11:31

RNS Number : 9900O
Canaccord Genuity Limited
04 February 2019
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MedicX Fund Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the Offeree

 

(d) Date dealing undertaken:

1 February 2019

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

Ordinary NPV

 

Buy

Sell

 

200,000

52,714

 

89p

90p

 

 

89p

88.8p

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

Date of disclosure:

4 February 2019

Contact name:

Sam Holland

Telephone number:

020 7523 8337

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREAFALEDENEFF
Date   Source Headline
25th Jul 20163:26 pmRNSAcquisition of new primary healthcare centre
8th Jul 20164:40 pmRNSSale of ordinary shares out of treasury
1st Jul 20164:00 pmRNSTotal voting rights
1st Jul 20164:00 pmRNSAllotment of scrip shares to Investment Adviser
1st Jul 20164:00 pmRNSAllotment of scrip shares
14th Jun 20167:00 amRNSScrip Dividend Declaration
1st Jun 20162:10 pmRNSSale of ordinary shares out of treasury
26th May 20163:35 pmRNSScrip Calculation Price for the June 2016 Dividend
24th May 20165:55 pmRNSPublication of Circular - Scrip Dividend Scheme
24th May 20167:00 amRNSInterim Results
4th May 20167:00 amRNSNotice of dividend
1st Apr 20161:00 pmRNSAllotment of scrip shares to Company Directors
1st Apr 20161:00 pmRNSAllotment of scrip shares to Investment Adviser
1st Apr 20161:00 pmRNSTotal voting rights
14th Mar 20169:41 amRNSScrip Dividend Declaration
10th Mar 201610:53 amRNSAcquisition of a new primary healthcare centre
10th Mar 20169:36 amRNSSale of ordinary shares out of treasury
25th Feb 20161:05 pmRNSScrip Calculation Price for March 2016 Dividend
24th Feb 201610:07 amRNSPublication of Circular - Scrip Dividend Scheme
18th Feb 20165:41 pmRNSSale of ordinary shares out of treasury
16th Feb 20162:45 pmRNSAnnual General Meeting results
10th Feb 20167:00 amRNSAcquisition of a new primary healthcare centre
8th Feb 20165:30 pmRNSQuarterly NAV and business update
2nd Feb 20167:00 amRNSNotice of dividend
28th Jan 20165:03 pmRNSSale of ordinary shares out of treasury
8th Jan 20163:39 pmRNSSale of ordinary shares out of treasury
4th Jan 20167:00 amRNSAllotment of scrip shares to Directors
4th Jan 20167:00 amRNSTotal voting rights
4th Jan 20167:00 amRNSAllotment of scrip shares to Investment Adviser
23rd Dec 20159:11 amRNSAcquisition of new primary healthcare centre
18th Dec 201512:50 pmRNSPosting of Annual Report and Notice of AGM
16th Dec 20155:05 pmRNSSale of ordinary shares out of treasury
10th Dec 20157:00 amRNSScrip Dividend Declaration
9th Dec 20153:35 pmRNSSale of ordinary shares out of treasury
9th Dec 20157:00 amRNSResults for the year ended 30 September 2015
26th Nov 20154:52 pmRNSScrip Calculation Price
26th Nov 20154:50 pmRNSAcquisition of a new primary healthcare centre
24th Nov 201510:32 amRNSPublication of Circular to Shareholders
23rd Nov 20159:30 amRNSAmendment to Investment Adviser fee structure
26th Oct 20152:22 pmRNSNotice of dividend
23rd Oct 20154:52 pmRNSAcquisition of four primary healthcare centres
1st Oct 201511:43 amRNS£50 million private placement of loan notes
1st Oct 20157:00 amRNSAllotment of scrip shares to Directors
1st Oct 20157:00 amRNSTotal voting rights
11th Sep 20153:43 pmRNSScrip Dividend Declaration
20th Aug 201512:04 pmRNSScrip Calculation Price for Sept 2015 Scrip Div
18th Aug 20157:00 amRNSPublication of Circular - Scrip Dividend Scheme
3rd Aug 20152:55 pmRNSQuarterly Net Asset Value ("NAV") announcement
3rd Aug 20157:00 amRNS£50 million loan note extension
28th Jul 20157:00 amRNSNotice of dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.